Life Sciences Investment

Showing 2787 articles
Business

SEI Investments: A 66% Five-Year Surge Raises Valuation Questions

SEI Investments (SEIC) has delivered impressive returns for shareholders over the past five years, but a closer look at its current valuation suggests the stock may have run ahead of its fundamentals. With shares trading near $88, analysis indicates potential overvaluation, prompting investors to weigh future growth against present price.

Business

Gilead Sciences Oncology Update After Positive Trodelvy Keytruda Trial Results

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...